Jean Galtier

12PUBLICATIONS
53CO-AUTHORS
Haematological tumoursAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)HaematologyCellular immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 14, 2026
Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.

Vincent Camus, Daphné Krzisch, Alessio Bruscaggin

|Dec 08, 2025
Cutaneous diffuse large B-cell lymphoma induces a macrophage immunosuppressive phenotype through IL-10 secretion.

Jean Galtier, Remi Peanne, Valérie Le Morvan

|May 01, 2025
TRANSCAR: real-world outcomes of CD19 CAR T-cell therapy in relapsed/refractory transformed indolent lymphomas.

Pierre Stephan, Roberta Di Blasi, Louise Roulin

|Feb 19, 2025
Outcomes of patients with relapsed or refractory primary mediastinal B-cell lymphoma treated with anti-CD19 CAR-T cells: CARTHYM, a study from the French national DESCAR-T registry.

Jean Galtier, Charles Mesguich, Pierre Sesques

|Jan 29, 2025
Relapsed Philadelphia chromosome-positive B-cell acute lymphoblastic leukaemia responds well to a combination of modified hyper-CVAD, blinatumomab and tyrosine kinase inhibitor.

Gaétan Basile, Jean Galtier, Titouan Cazaubiel

|Nov 18, 2024
Mini-consolidations or intermediate-dose cytarabine for the post-remission therapy of AML patients over 60. A retrospective study from the DATAML and SAL registries.

Christian Récher, Pierre-Yves Dumas, Emilie Bérard

Pageof 2

Frequent Collaborators

3 joint publications

Vincent Camus

2 joint publications

Marie Donzel

2 joint publications

Roch Houot

2 joint publications

Jean Baptiste Rieu